RecruitingNCT07424404

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Medication studyAges 5–17Multiple countriesSchizophrenia

The study in practice

Understand this study

Who could participate?

Listed age limits: 5 years to 17 years.

Listed locations: Dothan, United States · Phoenix, United States and 88 more locationsSee all locations and recruitment
Activities: Medication described in the protocol
Compensation: Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 7, 2026

Recruitment status: Recruiting
Enrollment listed in the registry: 400
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sponsor type: Biotech company
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: United States, Australia, France, ...
Age range: From 5 Years to 17 Years
Official registry ID: NCT07424404
Official title: Show the full official title
A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride in Children and Adolescents With Psychiatric Disorders

Need help understanding this study?

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Recruitment & locations

Recruiting

Dothan, United States · Phoenix, United States · Anaheim, United States

87 more locations

Chino, United States
Culver City, United States
Glendale, United States
Los Angeles, United States
Orange, United States
San Diego, United States
San Francisco, United States
San Rafael, United States
New Haven, United States
Boca Raton, United States
Gainesville, United States
Hollywood, United States
Orlando, United States
Atlanta, United States
Decatur, United States
Lawrenceville, United States
Stone Mountain, United States
Chicago, United States
Louisville, United States
Boston, United States
Lexington, United States
Worcester, United States
Bloomfield Hills, United States
Columbia, United States
Saint Charles, United States
Lincoln, United States
Las Vegas, United States
Neptune City, United States
Great Neck, United States
Orangeburg, United States
Staten Island, United States
The Bronx, United States
Cincinnati, United States
West Chester, United States
Danville, United States
Pittsburgh, United States
Nashville, United States
Dallas, United States
Garland, United States
Houston, United States
Plano, United States
San Antonio, United States
Spring, United States
Orem, United States
West Point, United States
Richmond, United States
Everett, United States
Westmead, Australia
Brisbane, Australia
Melbourne, Australia
Calgary, Canada
Edmonton, Canada
Kingston, Canada
Toronto, Canada
Montreal, Canada
Bordeaux, France
Bron, France
Paris, France
Budapest, Hungary
Gyula, Hungary
Szeged, Hungary
Kozhikode, India
Nagpur, India
Kanpur, India
Kolkata, India
Chikugo, Japan
Sapporo, Japan
Zentsujichó, Japan
Miyakonojō, Japan
Bunkyo-ku, Japan
Ōta-ku, Japan
Yokohama, Kanagawa, Japan
Poznan, Poland
Wroclaw, Poland
Warsaw, Poland
Gdansk, Poland
Szczecin, Poland
Katowice, Poland
Lublin, Poland
Zabrze, Poland
San Juan, Puerto Rico
Bucharest, Romania
Cluj-Napoca, Romania
Iași, Romania
Timișoara, Romania
Barcelona, Spain
Madrid, Spain

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Karuna Therapeutics, Inc., a Bristol Myers Squibb company.

Does this study involve medication?

Yes. The study involves medication, including KarXT and KarX-EC.

Who can participate?

Listed age limits: 5 years to 17 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me